For chronic weight management, the higher-dose injectable formulation (Wegovy) is approved for adults with a body mass index (BMI) of 30 kg/m or greater (obesity), or a BMI of 27 kg/m or greater (overweight) in the presence of at least one weight-related comorbid condition
At EndoSlim Clinic NY, Dr
It is not intended for human or animal consumption, therapeutic use, or any form of self-administration
Is it safe for a mother with multiple thyroid nodules to use GLP-1 (Glucagon-like peptide-1) receptor agonists, such as liraglutide (Victoza) or semaglutide (Ozempic), for weight loss or metabolic control?
9 people find this information helpful Disclaimer We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers
Terushkin at his Goal BMI Clinic, combined with self-pay options and insurance coverage, ensures that this revolutionary medication is within reach